Event overview

Left behind in pain: the hidden pandemic of untreated suffering (Raffaella Ravinetto)

During this lecture (Spectrumlezing, University of Antwerp), Prof Dr Raffaella Ravinetto will explore global inequalities in access to essential medicines. Registration opens on 5 October via the University of Antwerp website.
-

UAntwerpen (TBD)

Register now
Opioids_Header_5x4

About this event

So-called "controlled medicines", including many narcotic and psychotropic substances, have a dual nature: they are essential for healthcare, yet potentially harmful when misused. Finding the right balance between ensuring access for medical purposes and preventing misuse remains a major challenge. This challenge is also marked by profound global inequalities. While the United States struggles to contain the opioid overdose epidemic, millions of patients in low- and middle-income countries and conflict-affected settings suffer severe pain simply because they lack access to morphine.

This lecture will examine the causes of this global gap, which also affects other medicines used in anaesthesia, neurological disorders, opioid dependence treatment, and palliative care. We will explore potential solutions from different perspectives, including regulation, healthcare, the pharmaceutical sector, social sciences, human rights, and law. Particular attention will be given to collaboration in research to address knowledge gaps and to expanding international exchange of expertise.

Practical info

Date: 22 October 2026
Time:
14:15-16:00 (CEST)
Location: University of Antwerp (Campus TBD)
Format: In person
Language: English
Registration:
Registration opens on 5 October via the UAntwerp website.

More info
RaffaellaRavinetto_5x4 Prof Dr Raffaella Ravinetto

Speaker

Raffaella Ravinetto

Prof Dr Raffaella Ravinetto is Associate Professor of Pharmaceutical Public Health and Head of the Department of Public Health at the Institute of Tropical Medicine in Antwerp, and Extraordinary Professor at the School of Public Health of the University of the Western Cape in South Africa. Originally trained as a pharmacist, she has built professional experience in both commercial and non-commercial clinical trials, humanitarian programmes, research and teaching on pharmaceutical policies and pharmaceutical systems, as well as ethics review. Issues related to equitable access to quality-assured health products, with particular attention to vulnerable populations, are at the core of her research group's work.

Spread the word! Share this event on